Sector consensus Caplin Point Laboratories Limited NSE India S.E.
Stocks
CAPLIPOINT
INE475E01026
Pharmaceuticals
|
Market Closed -
NSE India S.E.
09:05:07 11/09/26 pm AEST
|
5-day change | 1st Jan Change | ||
| 2,754.90 INR | -1.45% |
|
-1.99% | +49.88% |
| 15/08 | Caplin Point Laboratories Limited, Q1 2027 Earnings Call, Aug 12, 2026 | |
| 12/08 | Caplin Point Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| 2,167.21 | +16.45% | 33 | |||||||
| 14,433.33 | +25.89% | 12 | |||||||
| 1,195.78 | +6.98% | 30 | |||||||
| 1,509.08 | +9.89% | 36 | |||||||
| 257.83 | -1.21% | 6 | |||||||
| 13,214.57 | +5.8% | 7 | |||||||
| 2,497.73 | +3.43% | 11 | |||||||
| - | 2,508.33 | +7.03% | 12 | ||||||
| - | - | - | - | - | |||||
| 3,796.46 | +7.85% | 13 | |||||||
| 172.67 | +10.22% | 3 | |||||||
| 15.11 | +57.24% | 4 | |||||||
| - | - | 133.12 | -1.1% | 2 | |||||
| - | - | - | - | - | |||||
| - | 154.68 | +12.74% | 4 | ||||||
| - | - | 14.6 | +7.59% | 1 | |||||
| Average | 3,005.04 | +12.06% | 12 | ||||||
| Weighted average by Cap. | 5,308.58 | +15.11% | 20 |
Select your edition
All financial news and data tailored to specific country editions
















